Ticker Details
Jazz Pharmaceuticals plc Jazz Pharmaceuticals PLC is a biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.
IPO Date:	June 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$15.05B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.44 | 1.97%
Avg Daily Range (30 D):	$2.68 | 1.27%
Avg Daily Range (90 D):	$2.39 | 1.26%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	.78M
Avg Daily Volume (90 D):	.78M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	10,781
Avg Institutional Trade:	$4.93M
Avg Institutional Trade (30 D):	$10.91M
Avg Institutional Trade (90 D):	$9.33M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$8.49M
Avg Closing Trade (30 D):	$25.12M
Avg Closing Trade (90 D):	$22.64M
Avg Closing Volume:	63.72K

News

May 13, 2026 @ 10:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Apr 20, 2026 @ 5:00 PM Pheochromocytoma and Paraganglioma Market to Exhib... Source: Delveinsight

Feb 16, 2026 @ 1:00 PM Artios Strengthens Leadership Team to Accelerate L... Source: Not Specified

Feb 12, 2026 @ 11:00 AM Zymeworks To Report Fourth Quarter and Full Year 2... Source: Na

Jan 27, 2026 @ 5:02 PM Harmony Biosciences' Sales and Profits Have Soared... Source: Dan Caplinger

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$4.73	$4.14
Diluted EPS		$4.43	$4.08
Revenue		$1.07B	$1.13B
Gross Profit
Net Income / Loss		$293.1M	$251.41M
Operating Income / Loss		$336.6M	$57.51M
Cost of Revenue
Net Cash Flow		$452.4M	$136.19M
PE Ratio